Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 270

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 270
---
 of options to purchase 504 shares of common stock at a weighted average
price of $436.00.

<div align='center'>157</div>

As of October 1, 2024, the
board of directors has approved option awards to the executive officers for 2024, as set forth below:

| Name and Position                        |     | Stock   
 Options |        |
| Chris Ehrlich,                           
 Chief Executive Officer and Chairman (1) |     |         | 25,500 |
| Andrew “Al”                              
 Kucharchuk, Chief Financial Officer      |     |         |  5.000 |
| Kristen Pierce, Chief                    
 Development Officer                      |     |         |  2,659 |
| Brian G. Atwood, Former                  
 Chief Executive Officer and Chairman (2) |     |         |  5,080 |
| Charles R. Carter, Former                
 Chief Financial Officer (3)              |     |         |      - |
| Daniel Corey, M.D., Former               
 Chief Technology Officer (4)             |     |         |      - |

| (1) | Excludes 5,272 options                                                  
 granted under the 2024 Plan which were forfeited on September 30, 2024. |
| (2) | Excludes 13,318 options                                                 
 granted under the 2024 Plan which were forfeited on September 30, 2024. |
| (3) | Excludes 4,954 options                                                  
 granted under the 2024 Plan which were forfeited on September 30, 2024. |
| (4) | Excludes 4,613 options                                                  
 granted under the 2024 Plan which were forfeited on September 23, 2024. |

Compensation Recovery Policy

Our board of directors adopted
a Compensation Recovery Policy (the “Compensation Recovery Policy”), in compliance with the Nasdaq listing rules, which requires
recovery from executive officers of incentive-based compensation that is earned, granted or vested based on the achievement of a financial
reporting measure in the event of a required accounting restatement of previously issued financial statements. The recoverable compensation
includes any compensation received after the effective date of the Compensation Recovery Policy and in the three-year fiscal period preceding
the date we were required to prepare the accounting restatement that is in excess of the amount that would have been earned, paid or
vested had it been calculated based on the restated financial statements. Recovery is required